Literature DB >> 19956519

Expression of maspin is associated with the intestinal type of gastric adenocarcinoma.

Seong Man Kim1, Seong Jin Cho, Woo Young Jang, Duck Hwan Kim, Hyung Sik Shin, Myoung Kuk Jang, Hak Yang Kim, Eun Sook Nam.   

Abstract

PURPOSE: Maspin is known as a tumor suppressor gene, but its significance has been questioned in various human cancers. The aim of this study was to investigate the expression pattern of Maspin in human gastric adenocarcinomas and its possible correlation with clinicopathological findings.
MATERIALS AND METHODS: The expression of Maspin mRNA was measured by nested RT-PCR using 60 frozen adenocarcinomas of the stomach and 31 noncancerous tissues from the proximal resection margin. Immunohistochemical study for Maspin protein expression was carried out using 62 paraffin-embedded tissues, composed of both cancer and noncancerous tissues.
RESULTS: Maspin mRNA expression was detected in 80.0% (48 of 60) of the gastric adenocarcinomas, but in only 22.6% (7 of 31) of the normal gastric mucosa (p<0.001). The positive rate of Maspin protein expression was higher in the adenocarcinomas than the normal tissues (62.9% vs. 27.4%, p<0.05). In addition, the intestinal type of tumors showed significantly higher expression levels compared to the diffuse type of tumors (81.5% vs. 48.6%, p<0.05).
CONCLUSION: Our results suggest that Maspin is frequently expressed in human gastric cancers, and its expression might be associated with tumorigenesis of the intestinal type of gastric cancer.

Entities:  

Keywords:  Gastric adenocarcinoma; Immunohistochemistry; Maspin; Nested RT-PCR

Year:  2005        PMID: 19956519      PMCID: PMC2785921          DOI: 10.4143/crt.2005.37.4.228

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  24 in total

1.  Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin.

Authors:  M Zhang; N Maass; D Magit; R Sager
Journal:  Cell Growth Differ       Date:  1997-02

2.  Production, purification, and characterization of recombinant maspin proteins.

Authors:  S Sheng; P A Pemberton; R Sager
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

3.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells.

Authors:  Z Zou; A Anisowicz; M J Hendrix; A Thor; M Neveu; S Sheng; K Rafidi; E Seftor; R Sager
Journal:  Science       Date:  1994-01-28       Impact factor: 47.728

4.  Aberrant expression of the maspin gene associated with epigenetic modification in melanoma cells.

Authors:  Kei Wada; Chihaya Maesawa; Toshihide Akasaka; Tomoyuki Masuda
Journal:  J Invest Dermatol       Date:  2004-03       Impact factor: 8.551

Review 5.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention.

Authors:  P Correa
Journal:  Cancer Res       Date:  1992-12-15       Impact factor: 12.701

6.  A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene.

Authors:  S S Schneider; C Schick; K E Fish; E Miller; J C Pena; S D Treter; S M Hui; G A Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

7.  Maspin expression and its clinicopathological significance in tumorigenesis and progression of gastric cancer.

Authors:  Meng-Chun Wang; Yan-Min Yang; Xiao-Han Li; Fang Dong; Yan Li
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

8.  Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers.

Authors:  Satoshi Ogasawara; Chihaya Maesawa; Masahide Yamamoto; Yuji Akiyama; Kei Wada; Kentaro Fujisawa; Taro Higuchi; Yuki Tomisawa; Nobuhiro Sato; Shigeatsu Endo; Kazuyoshi Saito; Tomoyuki Masuda
Journal:  Oncogene       Date:  2004-02-05       Impact factor: 9.867

9.  Relationship between lymph node sinuses with blood and lymphatic metastasis of gastric cancer.

Authors:  Tong Yin; Xiao-Long Ji; Min-Shi Shen
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

10.  Prognostic significance of maspin in pancreatic ductal adenocarcinoma.

Authors:  Yun Jeong Lim; Jong Kyun Lee; Woo Young Jang; Sang Yong Song; Kyu Taek Lee; Seung Woon Paik; Jong Chul Rhee
Journal:  Korean J Intern Med       Date:  2004-03       Impact factor: 2.884

View more
  3 in total

1.  Analysis of co-expression networks for circular RNAs and mRNAs reveals that circular RNAs hsa_circ_0047905, hsa_circ_0138960 and has-circRNA7690-15 are candidate oncogenes in gastric cancer.

Authors:  Zhiyong Lai; Yang Yang; Yichao Yan; Tao Li; Yansen Li; Zhu Wang; Zhanlong Shen; Yingjiang Ye; Kewei Jiang; Shan Wang
Journal:  Cell Cycle       Date:  2017-11-09       Impact factor: 4.534

2.  Prognostic value of nuclear maspin expression for adjuvant 5-fluorouracil-based chemotherapy in advanced gastric cancer.

Authors:  Ke-Feng Lei; Bing-Ya Liu; Xiao-Long Jin; Yan Guo; Min Ye; Zheng-Gang Zhu
Journal:  Exp Ther Med       Date:  2012-03-30       Impact factor: 2.447

3.  The roles of maspin expression in gastric cancer: a meta- and bioinformatics analysis.

Authors:  Hua-Chuan Zheng; Bao-Cheng Gong
Journal:  Oncotarget       Date:  2017-08-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.